sur ABIVAX (EPA:ABVX)
Abivax unveils its financial calendar for 2025
French biotech company Abivax has released its financial reporting calendar for 2025. The announcement includes several key dates for shareholders and investors. On March 24, the company will release its 2024 annual report, followed by Q1 2025 financial results on June 2. A general shareholders’ meeting is scheduled for June 6 in Paris.
The half-year and financial report will be presented on August 11, and the third quarter 2025 results will be communicated on December 15. These publications will be made after the close of the American market. These regular steps aim to inform investors of Abivax's financial developments throughout the year.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABIVAX